Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Health Catalyst (HCAT) Receivables - Net (2018 - 2025)

Health Catalyst's Receivables - Net history spans 8 years, with the latest figure at $59.1 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 3.4% year-over-year to $59.1 million; the TTM value through Dec 2025 reached $59.1 million, up 3.4%, while the annual FY2025 figure was $59.1 million, 3.4% up from the prior year.
  • Receivables - Net reached $59.1 million in Q4 2025 per HCAT's latest filing, down from $60.1 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $68.4 million in Q2 2025 to a low of $42.6 million in Q1 2022.
  • Average Receivables - Net over 5 years is $53.4 million, with a median of $52.0 million recorded in 2023.
  • Peak YoY movement for Receivables - Net: soared 45.12% in 2023, then decreased 12.91% in 2024.
  • A 5-year view of Receivables - Net shows it stood at $48.8 million in 2021, then decreased by 1.7% to $48.0 million in 2022, then increased by 25.68% to $60.3 million in 2023, then dropped by 5.16% to $57.2 million in 2024, then grew by 3.4% to $59.1 million in 2025.
  • Per Business Quant, the three most recent readings for HCAT's Receivables - Net are $59.1 million (Q4 2025), $60.1 million (Q3 2025), and $68.4 million (Q2 2025).